Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.
[cushing syndrome]
Nowadays
,
unwanted
pregnancy
is
a
major
globe
tragedy
for
millions
of
women
,
associated
with
significant
direct
and
indirect
costs
,
no
matter
for
individuals
or
society
.
The
progesterone
receptor
antagonist
steroid
,
mifepristone
has
been
widely
and
effectively
using
throughout
the
world
for
medical
abortion
,
but
to
a
lesser
extent
for
emergency
contraception
.
In
this
review
,
we
hope
to
explore
the
role
of
mifepristone
as
a
contraceptive
,
particularly
for
emergency
contraception
.
Studies
of
mifepristone
have
also
been
expanding
to
the
fields
of
endometriosis
and
uterine
fibroids
.
Furthermore
,
this
initially
considered
reproductive
medicine
has
been
investigated
in
some
psychotic
diseases
and
various
disorders
of
hypercortisolism
,
because
of
its
glucocorticoid
receptor
antagonism
.
Mifepristone
was
approved
suitable
for
patients
with
hyperglycemia
secondary
to
Cushing
's
syndrome
by
the
United
States
Food
and
Drug
Administration
(
FDA
)
in
2012
.
The
aim
of
this
article
is
to
review
published
reports
on
the
anti-progesterone
and
anti-glucocorticoid
properties
of
mifepristone
as
a
clinical
agent
.
There
is
a
new
insight
into
systematically
describing
and
evaluating
the
potential
efficiency
of
mifepristone
administrated
in
the
field
of
endocrine
and
neuroendocrine
,
not
only
in
obstetrics
and
gynecology
.
Diseases
Validation
Diseases presenting
"because of its glucocorticoid receptor antagonism"
symptom
cushing syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom